2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma

被引：0

作者：

Graham, Jeffrey ^{[1
]}

Ahmad, Ardalan E. ^{[2
]}

Basappa, Naveen S. ^{[3
]}

Bernhard, Jean-Christophe ^{[4
]}

Bhindi, Bimal ^{[5
]}

Bosse, Dominick ^{[6
]}

Breau, Rodney H. ^{[7
]}

Canil, Christina M. ^{[6
]}

Castonguay, Vincent ^{[8
]}

Finelli, Antonio ^{[9
]}

Heng, Daniel Y. C. ^{[10
]}

Inman, Brant A. ^{[11
]}

Kollmannsberger, Christian ^{[12
]}

Lalani, Aly-Khan A. ^{[13
]}

Lavallee, Luke T. ^{[7
]}

Msaouel, Pavlos ^{[14
]}

Prendeville, Susan ^{[15
]}

Soleimani, Maryam ^{[16
]}

Tanguay, Simon ^{[17
]}

Wood, Lori ^{[18
]}

Richard, Patrick O. ^{[19
,20
,21
]}

机构：

[1] Univ Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada

[2] Univ Manitoba, Dept Surg, Div Vasc Surg, Winnipeg, MB, Canada

[3] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada

[4] CHU Bordeaux, Dept Urol, Bordeaux, France

[5] Univ Calgary, Dept Surg, Sect Urol, Calgary, AB, Canada

[6] Univ Ottawa, Ottawa Hosp Res Inst, Div Med Oncol, Ottawa, ON, Canada

[7] Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Div Urol, Ottawa, ON, Canada

[8] Univ Laval, Chu Quebec, Quebec City, PQ, Canada

[9] Univ Toronto, Princess Margaret Hosp, Dept Surg, Div Urol, Toronto, ON, Canada

[10] Univ Calgary, Arthur JE Child Comprehens Canc Ctr, Dept Dept Oncol 10, Calgary, AB, Canada

[11] Western Univ, Div Urol, London, ON, Canada

[12] BC Canc, Vancouver Ctr, Dept Med Oncol, Vancouver, BC, Canada

[13] McMaster Univ, Juravinski Canc Ctr, Dept Oncol, Hamilton, ON, Canada

[14] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA

[15] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada

[16] Univ British Columbia, BC Canc Vancouver Ctr, Dept Med, Med Oncol Div, Vancouver, BC, Canada

[17] McGill Univ, Hlth Ctr, Div Urol, Montreal, PQ, Canada

[18] Dalhousie Univ, Div Med Oncol, Halifax, NS, Canada

[19] Ctr Hosp Univ Sherbrooke, Div Urol, Sherbrooke, PQ, Canada

[20] Univ Sherbrooke, Canc Res Inst, Sherbrooke, PQ, Canada

[21] Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Dept Surg, Div Urol, Sherbrooke, PQ, Canada

来源：

CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2024年 / 18卷 / 11期

关键词：

CYTOREDUCTIVE NEPHRECTOMY; TARGETED-THERAPY; KIDNEY CANCER; SYNCHRONOUS METASTASES; ACTIVE SURVEILLANCE; PATIENTS PTS; OPEN-LABEL; SURVIVAL; SUNITINIB; NIVOLUMAB;

D O I：

10.5489/cuaj.9041

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E371 / E386

页数：16

共 50 条

[31] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
Ismail Selvi
Umut Demirci
Nazan Bozdogan
Halil Basar
International Urology and Nephrology, 2021, 53 : 1135 - 1138
[32] Time to Focus on the Rare-Encouraging Progress in the Management of Non-clear Cell Renal Cell Carcinoma
Fernando, Archie
EUROPEAN UROLOGY, 2017, 72 (06) : 984 - 985
[33] Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options
Wilson, Nathaniel R.
Acikgoz, Yusuf
Hasanov, Elshad
INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (06) : 947 - 961
[34] Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma
Han, Seung Hun
Camp, Sabrina Y.
Chu, Hoyin
Collins, Ryan
Gillani, Riaz
Park, Jihye
Bakouny, Ziad
Ricker, Cora A.
Reardon, Brendan
Moore, Nicholas
Kofman, Eric
Labaki, Chris
Braun, David
Choueiri, Toni K.
AlDubayan, Saud H.
Van Allen, Eliezer M.
EUROPEAN UROLOGY OPEN SCIENCE, 2024, 62 : 107 - 122
[35] Non-Clear Cell Renal Cancer: Features and Medical Management
Heng, Daniel Y. C.
Choueiri, Toni K.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (06): : 659 - 665
[36] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
Selvi, Ismail
Demirci, Umut
Bozdogan, Nazan
Basar, Halil
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1135 - 1138
[37] Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features.
Chang, Guy vin
Ellithi, Moataz
Elnair, Radowan
Bleeker, Jonathan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[38] The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature
Ventriglia, Jole
Passarelli, Anna
Pisano, Carmela
Cecere, Sabrina Chiara
Rossetti, Sabrina
Feroce, Florinda
Forte, Miriam
Casartelli, Chiara
Tambaro, Rosa
Pignata, Sandro
Perversi, Fabio
Di Napoli, Marilena
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
[39] Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula
Kopp, Ryan P.
Aganovic, Lejla
Palazzi, Kerrin L.
Cassidy, Fiona H.
Sakamoto, Kyoko
Derweesh, Ithaar H.
CANADIAN JOURNAL OF UROLOGY, 2013, 20 (03) : 6790 - 6797
[40] Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
Lee, Jii Bum
Park, Hyung Soon
Park, Sejung
Lee, Hyo Jin
Kwon, Kyung A.
Choi, Young Jin
Kim, Yu Jung
Nam, Chung Mo
Cho, Nam Hoon
Kang, Beodeul
Chung, Hyun Cheol
Rha, Sun Young
CANCER RESEARCH AND TREATMENT, 2019, 51 (04): : 1578 - 1588

← 1 2 3 4 5 →